Shuyuan Yeh

18.4k citations

204 papers · 14.5k indexed · 2 hit papers · h-index 68

Reproductive Medicine top 0.2%
Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism 19
- Cancer-related molecular mechanisms research 16
Endocrinology, Diabetes and Metabolism top 0.2%
- Hormonal and reproductive studies 49
Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research 93
- Prostate Cancer Diagnosis and Treatment 14
Genetics top 0.2%
- Estrogen and related hormone effects 50
Surgery
- Bladder and Urothelial Cancer Treatments 19
Molecular Biology
- Circular RNAs in diseases 13

Co-authors: Chawnshang Chang Hong‐Yo Kang Hiroshi Miyamoto Hui‐Kuan Lin Saleh Altuwaijri Edward M. Messing Qingquan Xu Ruey-Sheng Wang
Cited by: Reproductive Medicine Cancer Research Endocrinology, Diabetes and Metabolism
Journals: Proceedings of the National Academy of Sciences (20 papers)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (12 papers)
Partner nations: United States Taiwan China

In The Last Decade

Shuyuan Yeh

203 papers receiving 14.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2002 Proceedings of the National Academy of Sciences
1996 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Shuyuan Yeh

Since Specialization

Citations

This map shows the geographic impact of Shuyuan Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyuan Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyuan Yeh more than expected).

Fields of papers citing papers by Shuyuan Yeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyuan Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyuan Yeh. The network helps show where Shuyuan Yeh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shuyuan Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuyuan Yeh Line = papers co-authored together Shuyuan Yeh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The androgen receptor in bladder cancer Nature Reviews Urology ·Jinbo Chen,Chi‐Ping Huang,Chao Quan,Xiongbing Zu,Zhenyu Ou,Yu‐Chieh Tsai,Edward M. Messing,Shuyuan Yeh,Chawnshang Chang	2023	29
2	Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling Cancer Gene Therapy ·Qing Liu,Bosen You,Jialin Meng,Chi‐Ping Huang,Guanglu Dong,Ronghao Wang,Fu-Ju Chou,Shan Gao,Chawnshang Chang,Shuyuan Yeh,Wanhai Xu	2022	36
3	The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer Nature Communications ·Keliang Wang,Jie Luo,Shuyuan Yeh,Bosen You,Jialin Meng,Philip Chang,Yuanjie Niu,Gonghui Li,Changxue Lu,Yezi Zhu,Emmanuel S. Antonarakis,Jun Luo,Chi‐Ping Huang,Wanhai Xu,Chawnshang Chang	2020	52
4	Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling Oncogene ·Jinbo Chen,Fu-Ju Chou,Shuyuan Yeh,Zhenyu Ou,Chih‐Rong Shyr,Chi‐Ping Huang,Zhendong Xiang,Yin Sun,Edward M. Messing,Xiongbing Zu,Chawnshang Chang	2019	31
5	ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma Cancer Research ·Zhenwei Han,Yong Zhang,Yin Sun,Jiaqi Chen,Chawnshang Chang,Xiaolu Wang,Shuyuan Yeh	2018	65
6	Androgen receptor (AR) degradation enhancer ASC-J9 ® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth Cancer Letters ·Max A. Cheng,Fu-Ju Chou,Keliang Wang,Rachel Yang,Jie Ding,Qiaoxia Zhang,Gonghui Li,Shuyuan Yeh,Defeng Xu,Chawnshang Chang	2017	38
7	Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals Molecular Cancer Therapeutics ·Le Tao,Jianxin Qiu,Ming Jiang,Wenbin Song,Shuyuan Yeh,Hong Yu,Lijuan Zang,Shujie Xia,Chawnshang Chang	2016	18
8	Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression Molecular Cancer Therapeutics ·Liang Shi,Hui Lin,Gonghui Li,Ren-An Jin,Junjie Xu,Yin Sun,Wen‐Lung Ma,Shuyuan Yeh,Xiujun Cai,Chawnshang Chang	2016	46
9	Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression Molecular Cancer Therapeutics ·Zhiqun Shang,Yanjun Li,Minghao Zhang,Jing Tian,Ruifa Han,Chih‐Rong Shyr,Edward M. Messing,Shuyuan Yeh,Yuanjie Niu,Chawnshang Chang	2015	36
10	ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor–Dependent HIF2α/VEGF Signaling Pathway Cancer Research ·Dalin He,Lei Li,Guodong Zhu,Liang Liang,Zhenfeng Guan,Luke S. Chang,Yuan Chen,Shuyuan Yeh,Chawnshang Chang	2014	81
11	Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals Molecular Cancer Therapeutics ·Xiaohai Wang,Soo Ok Lee,Shujie Xia,Qi Jiang,Jie Luo,Lei Li,Shuyuan Yeh,Chawnshang Chang	2013	82
12	Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver Oncogene ·Chawnshang Chang,S O Lee,Shuyuan Yeh,T. M. Chang	2013	178
13	New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells Journal of Molecular Cell Biology ·Soo Ok Lee,Zhifang Ma,Chiuan-Ren Yeh,Jie Luo,Tzu‐Hua Lin,Kuo-Pao Lai,Shinichi Yamashita,Liang Liang,Jing Tian,Lei Li,Qi Jiang,Chiung-Kuei Huang,Yuanjie Niu,Shuyuan Yeh,Chawnshang Chang	2012	79
14	Increased CK5/CK8-Positive Intermediate Cells with Stromal Smooth Muscle Cell Atrophy in the Mice Lacking Prostate Epithelial Androgen Receptor PLoS ONE ·Yuanjie Niu,Juan Wang,Zhiqun Shang,Shu‐Pin Huang,Chih‐Rong Shyr,Shuyuan Yeh,Chawnshang Chang	2011	20
15	In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR -α-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer Clinical Cancer Research ·Jing Ni,Tiejun Mai,See-Tong Pang,Imranul Haque,Kaohsing Huang,Matthew A. DiMaggio,Shaozhen Xie,Nadine S. James,Dhanalakshmi Kasi,Sherry R. Chemler,Shuyuan Yeh	2009	4
16	Dual expression of α-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of α-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas Modern Pathology ·Sharlin Johnykutty,Ping Tang,Hongwei Zhao,David G. Hicks,Shuyuan Yeh,Xi Wang	2009	12
17	Androgen receptor is a tumor suppressor and proliferator in prostate cancer Proceedings of the National Academy of Sciences ·Yuanjie Niu,Saleh Altuwaijri,Kuo‐Pao Lai,Chun‐Te Wu,William A. Ricke,Edward M. Messing,Jorge L. Yao,Shuyuan Yeh,Chawnshang Chang	2008	211
18	Tissue Prostate-Specific Antigen Facilitates Refractory Prostate Tumor Progression via Enhancing ARA70-Regulated Androgen Receptor Transactivation Cancer Research ·Yuanjie Niu,Shuyuan Yeh,Hiroshi Miyamoto,Gonghui Li,Saleh Altuwaijri,Jianqun Yuan,Ruifa Han,MA Teng-xiang,Hann‐Chorng Kuo,Chawnshang Chang	2008	68
19	ARA67/PAT1 Functions as a Repressor To Suppress Androgen Receptor Transactivation Molecular and Cellular Biology ·Yanqing Zhang,Yue Yang,Shuyuan Yeh,Chawnshang Chang	2004	31
20	Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissuesbreakdown → Proceedings of the National Academy of Sciences ·Shuyuan Yeh,Meng-Yin Tsai,Qingquan Xu,Xiao-Min Mu,Henry A. Lardy,Ko-En Huang,Hank Lin,Shauh-Der Yeh,Saleh Altuwaijri,Xinchang Zhou,Lianping Xing,Brendan F. Boyce,Mien‐Chie Hung,Su Zhang,Lin Gan,Chawnshang Chang	2002	534

About Shuyuan Yeh

Shuyuan Yeh is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Cancer Research, having authored 204 papers that have together received 14.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (93 papers), Estrogen and related hormone effects (50 papers), Hormonal and reproductive studies (49 papers), Bladder and Urothelial Cancer Treatments (19 papers), Cancer, Lipids, and Metabolism (19 papers), Cancer-related molecular mechanisms research (16 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Circular RNAs in diseases (13 papers). The work is most often cited by research in Reproductive Medicine (1.6k citations), Cancer Research (2.9k citations) and Endocrinology, Diabetes and Metabolism (2.7k citations). Shuyuan Yeh has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Chawnshang Chang, Hong‐Yo Kang, Hiroshi Miyamoto, Hui‐Kuan Lin, Saleh Altuwaijri, Edward M. Messing, Qingquan Xu, Ruey-Sheng Wang, Henry A. Lardy and Hong‐Chiang Chang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact